je.st
news
Amgen vaccine triggers immune response in advanced melanoma -study
2014-03-15 09:04:30| Biotech - Topix.net
An experimental Amgen Inc cancer vaccine used to treat advanced melanoma, the deadliest form of skin cancer, proved effective in a late-stage study in shrinking tumors in a way that suggests the drug triggered the intended systemic immune response, according to data presented on Friday.
Tags: advanced
study
response
immune
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||